Michel Bouvier
Chief Executive Officer, IRIC
Principal Investigator, Molecular Pharmacology Research Unit, IRIC
Professor, Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Université de Montréal
Principal Investigator, Molecular Pharmacology Research Unit, IRIC
Professor, Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Université de Montréal
Michel Bouvier has been Chief Executive Officer of IRIC since 2014. Following postdoctoral training in molecular pharmacology at Duke University, he joined the Department of Biochemistry and Molecular Medicine of the Université de Montréal, which he headed from 1997 to 2005, before joining IRIC. Specializing in cell signaling, he contributed to the development of drug research by founding initiatives such as IRICoR, the GRUM and the RQRM, and as a Board member of Univalor and MEDTEQ.